Cited 29 time in
Phytoextract-mediated synthesis of Cu doped NiO nanoparticle using cullon tomentosum plant extract with efficient antibacterial and anticancer property
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Indumathi, T. | - |
| dc.contributor.author | Hirad, Abdurahman Hajinur | - |
| dc.contributor.author | Alarfaj, Abdullah A. | - |
| dc.contributor.author | Ranjith Kumar, E. | - |
| dc.contributor.author | Chandrasekaran, Karthikeyan | - |
| dc.date.accessioned | 2024-08-08T10:00:46Z | - |
| dc.date.available | 2024-08-08T10:00:46Z | - |
| dc.date.issued | 2023-10 | - |
| dc.identifier.issn | 0272-8842 | - |
| dc.identifier.issn | 1873-3956 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/21076 | - |
| dc.description.abstract | In the present study, nickel oxide (NiO) and copper-doped nickel oxide (NiCuO) nanoparticles (NPs) were successfully synthesized using Cullen tomentosum plant extract with the co-precipitation method. This work focuses on the Phyto-mediated synthesis and characterization of NPs for their biological applications. Phytochemicals that exist in the plant extract acts as reducing and capping agent. The successful formation of the NPs was validated by various analysis as XRD, FESEM, EDAX, FT-IR, UV–Vis, and Photoluminescence. According to XRD studies, the average crystallite size of NiO and NiCuO NPs is 36 nm and 31 nm, respectively. The river stone and nanoflower like morphology for NiO and NiCuO NPs are confirmed by FESEM image. Furthermore, the synthesized NPs were tested against Gram-positive (Bacillus subtilis, Streptococcus pneumoniae) and Gram-negative (Klebsiella pneumoniae, Escherichia coli) bacteria, which showed enhanced antibacterial activity of NiCuO NPs. The cytotoxicity of NPs was investigated against human breast cancer cells (MDA-MB-231) and fibroblast L929 cell lines. Also, the IC50 value for human breast cancer cells is 11.8 μg/mL. According to these findings, NiCuO NPs are potential nanomaterials with advanced healthcare uses. © 2023 | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier Ltd | - |
| dc.title | Phytoextract-mediated synthesis of Cu doped NiO nanoparticle using cullon tomentosum plant extract with efficient antibacterial and anticancer property | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.ceramint.2023.07.142 | - |
| dc.identifier.scopusid | 2-s2.0-85166251425 | - |
| dc.identifier.wosid | 001148803500001 | - |
| dc.identifier.bibliographicCitation | Ceramics International, v.49, no.19, pp 31829 - 31838 | - |
| dc.citation.title | Ceramics International | - |
| dc.citation.volume | 49 | - |
| dc.citation.number | 19 | - |
| dc.citation.startPage | 31829 | - |
| dc.citation.endPage | 31838 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Materials Science | - |
| dc.relation.journalWebOfScienceCategory | Materials Science, Ceramics | - |
| dc.subject.keywordPlus | NICKEL-OXIDE NANOPARTICLES | - |
| dc.subject.keywordPlus | GREEN SYNTHESIS | - |
| dc.subject.keywordPlus | COPPER | - |
| dc.subject.keywordPlus | CYTOTOXICITY | - |
| dc.subject.keywordPlus | BIOSYNTHESIS | - |
| dc.subject.keywordPlus | SENSOR | - |
| dc.subject.keywordAuthor | Antibacterial activity | - |
| dc.subject.keywordAuthor | Anticancer activity | - |
| dc.subject.keywordAuthor | Cullon tomentosum | - |
| dc.subject.keywordAuthor | Cu–NiO NPs | - |
| dc.subject.keywordAuthor | Green synthesis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
